1Beasley RP, Hwang LY, Lin CC, et al. Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22 707 men in Taiwan. Lancet, 1981, 2:1129-1133.
2Gunther S, Li BC, Miska S, et al. A novel method for efficient amplification of whole hepatitis B virus genomes permits rapid functional analysis and reveals deletion mutants in immunosuppressed patients. J Virol, 1995,69:5437-5444.
3Blitz L, Pujol FH, Swenson PD, et al. Antigenic diversity of hepatitis B virus strains of genotype F in Amerindians and other population groups from Venezuela. J Clin Microbiol, 1998,36:648-651.
4Fiordalisi G, Ghiotto F, Castelnuovo F, et al. Analysis of the hepatitis B virus genome and immune response in HBsAg, anti-HBs positive chronic hepatitis. J Hepatol, 1994,20:487-493.
5Kao JH, Wu NH, Chen PJ, et al. Hepatitis B genotypes and the response to interferon therapy. J Hepatol, 2000,33:998-1002.
6Lo WY, Ting LP. Repression of enhancer Ⅱ activity by a negative regulatory element in the hepatitis B virus genome. J Virol, 1994, 68:1758-1764.
7Takahashi K, Akahane Y, Hino K, et al. Hepatitis B virus genomic sequence in the circulation of hepatocellular carcinoma patients: comparative analysis of 40 full-length isolates. Arch Virol, 1998,143:2313-2326.
8Friedt M, Gerner P, Lausch E, et al. Mutations in the basic core promotor and the precore region of hepatitis B virus and their selection in children with fulminant and chronic hepatitis B. Hepatology, 1999,29:1252-1258.
9Santantonio T, Jung MC, Schneider R, et al. Hepatitis B virus genomes that cannot synthesize pre-S2 proteins occur frequently and as dominant virus populations in chronic carriers in Italy. Virology, 1992, 188:948-952.
10Rossner MT. Review: hepatitis B virus X-gene product: a promiscuous transcriptional activator. J Med Virol, 1992,36:101-117.
8Mommeja - Marin H,Modndou E,Blum MR,et al. Serum HBV DNA as a marker of wfficacy during therapy for chronic HBV infection:analysis and review of the literature [ J ]. Hepatology, 2003,37 ( 6 ) : 1309 - 1319.
9第18届亚太肝病学年会[J].国际肝病,2008,12(4):10-10.
10Keeffc EB, Dieterich DT, Han SH, et al. A treatment algorithm for the management of chronic hepatitis B virus infection in the United States: an update [ J ]. Clin Gastroentrrol Hepatol, 2006,4:936 - 962.
